Go to navigation Go to content
Phone: 210-888-8888
Wayne Wright LLP
Call: 210-888-8888
Toll Free: 800-237-3334

Farxgia Poses Threat of Cancer and Deadly Infections in Diabetes Patients

Patients are already suffering dangerous side effects of the diabetes medication Invokana, but now a similar drug is under fire for causing potentially fatal injuries in patients. Farxiga, and its generic counterpart dapaglifozin, is raising concerns after reports of ketoacidosis, deadly infections, and certain forms of cancer

Why Is Farxgia Particularly Dangerous for Diabetes Sufferers?

When Farxiga was first submitted for approval in 2012, the FDA rejected the medication, noting an increased risk of breast and Yellow Danger Signbladder cancers. After a ruling from a review panel, drugmakers Bristol-Meyers Squibb Co. and AstraZeneca were able to secure FDA approval for Farxiga in 2014. However, the FDA did warn that patients with active bladder cancer should not take the drug.

Farxiga is just one of a class of drugs known as SGLT2 inhibitors, which have been linked to a number of severe health issues, including:

  • Ketoacidosis. If acid in the blood is allowed to build up, the blood itself becomes acidic—a potentially fatal condition known as ketoacidosis. Patients taking Farxiga should be vigilant in detecting the signs of ketoacidosis, including fruity-smelling breath, stomachaches, tiredness, trouble breathing, and vomiting, and seek medical treatment for these symptoms immediately.
  • Infections. Many patients taking this class of medications suffer urinary tract infections that progress to their blood or kidneys. Patients who experience pain during urination, fever, abdominal pain, or an urgent need to urinate while taking Farxiga should call their doctor to confirm and treat a urinary tract infection.
  • Cancer. One of the conditions of FDA approval for Farxiga was a post-market safety study on the risks and incidences of bladder cancer in patients. As late-stage bladder cancer may be fatal, patients should seek treatment for bladder cancer symptoms as soon as possible, such as kidney pain, blood in the urine, urinary pain, weight loss, and other unexplained symptoms.
  • Bone loss. While Farxiga has not yet been linked to skeletal problems, other SGLT2 medications (including Invokana) have been noted for their risks of increased fractures and low bone density.

What Should I Do If I Was Diagnosed With One of These Conditions?

If you suffered a severe health issue due to taking a diabetes medication, the drug company can be held liable for your hospital costs and loss of enjoyment of life. Our dangerous drugs attorneys can fight aggressively on your behalf, getting you the justice and compensation you deserve. Call us today at 800-237-3334 to discuss the details of your case in your free consultation.